Nebulizer Market is Projected to Grow at A CAGR of 6.8% During, 2020-2026

ABOUT THIS REPORT

OVERVIEW

Nebulizer Market was valued at $945.2 million by 2019; growing at a CAGR of 6.8% till 2026.

The nebulizer is a medical equipment used by people suffering from asthma or another respiratory condition. The nebulizer turns liquid medicine into a mist that a person can inhale through a face mask or mouthpiece. Nebulizers are available in two model’s tabletop and portable models. Tabletop nebulizers are larger and have to plug them into an electrical outlet. Portable nebulizers run on batteries or can plug them into a car outlet.

Rising prevalence of COPD, asthma, and other respiratory diseases are key driving factors of the market. For instance, according to the World Health Organization (WHO), each year 65 million people suffer from chronic obstructive pulmonary disease (COPD), and 3 million dies from it, which makes it the 3rd leading cause of death globally. Globally 334 million people have asthma, affecting 14% of all children. Each year 10 million people develop tuberculosis (TB), and 1.4 million dies from it. About 1.6 million people die each year from Lung cancer. About 4 million people die prematurely from the chronic respiratory disease globally. The nebulizer is used by people with asthma or another respiratory condition used to administer medication to the lungs.

Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer is the type segment of the market scope. By portability, the market is divided into Portable Nebulizer and Tabletop Nebulizer. By end-users, the global Nebulizer market is divided as Hospitals and Clinics, Emergency Centers, and Homecare settings. The report covers the value of the global market by type, portability, and end-users.

The market value mesh nebulizer was USD XX million in 2019, and it is expected to reach USD XX million by 2026, growing at a CAGR of XX during 2020-2026. Mesh nebulizer has shown significant growth in 2019, due to the increasing commercialization of new products and regulatory approval of mesh nebulizer.

North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global nebulizer value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America nebulizer market was USD XX million in 2019, and it is predicted to reach USD XX million by 2026, growing at a CAGR of XX during the forecast period. North America was dominating the global nebulizer market in 2019, due to the increasing prevalence of asthma, COPD and Respiratory Diseases, and commercialization of regulatory approved nebulizer.

Major players operating in the nebulizer industry include Becton, Dickinson and Company, Koninklijke Philips N.V., Rossmax International Ltd., OMRON Corporation, PARI Pharma, GF Health Products, Inc., Beurer GmbH, Vyaire Medical Inc., Agilent Technologies, Drive DeVilbiss Healthcare, Allied Healthcare Products, Inc., Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., Trudell Medical International, Dongguan Simzo Electronic Technology Co., Ltd, and HCmed Innovations Co., Ltd.

The partnership between companies to develop new products and provide investment to expand their presence globally and commercialization of new nebulizer are some of the strategies adopted by the companies.